Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab

Detalles Bibliográficos
Autores principales: De Schryver, Els, Calus, Lien, Van Zele, Thibaut, Bachert, Claus, Gevaert, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493504/
http://dx.doi.org/10.1186/2045-7022-5-S4-P41
_version_ 1782379929268125696
author De Schryver, Els
Calus, Lien
Van Zele, Thibaut
Bachert, Claus
Gevaert, Philippe
author_facet De Schryver, Els
Calus, Lien
Van Zele, Thibaut
Bachert, Claus
Gevaert, Philippe
author_sort De Schryver, Els
collection PubMed
description
format Online
Article
Text
id pubmed-4493504
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44935042015-07-15 Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab De Schryver, Els Calus, Lien Van Zele, Thibaut Bachert, Claus Gevaert, Philippe Clin Transl Allergy Poster Presentation BioMed Central 2015-06-26 /pmc/articles/PMC4493504/ http://dx.doi.org/10.1186/2045-7022-5-S4-P41 Text en Copyright © 2015 De Schryver et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
De Schryver, Els
Calus, Lien
Van Zele, Thibaut
Bachert, Claus
Gevaert, Philippe
Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
title Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
title_full Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
title_fullStr Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
title_full_unstemmed Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
title_short Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
title_sort comparison of different medical treatment options for crswnp: doxycycline, methylprednisolone, mepolizumab and omalizumab
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493504/
http://dx.doi.org/10.1186/2045-7022-5-S4-P41
work_keys_str_mv AT deschryverels comparisonofdifferentmedicaltreatmentoptionsforcrswnpdoxycyclinemethylprednisolonemepolizumabandomalizumab
AT caluslien comparisonofdifferentmedicaltreatmentoptionsforcrswnpdoxycyclinemethylprednisolonemepolizumabandomalizumab
AT vanzelethibaut comparisonofdifferentmedicaltreatmentoptionsforcrswnpdoxycyclinemethylprednisolonemepolizumabandomalizumab
AT bachertclaus comparisonofdifferentmedicaltreatmentoptionsforcrswnpdoxycyclinemethylprednisolonemepolizumabandomalizumab
AT gevaertphilippe comparisonofdifferentmedicaltreatmentoptionsforcrswnpdoxycyclinemethylprednisolonemepolizumabandomalizumab

Ejemplares similares